MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$15,805,268
Realized and accrued
interest income
$482,081
Unrealized gain
$3,980
Net loss
-$15,804,655
Total other
comprehensive loss
-$613
Total other income
$486,061
Total operating
expenses
$16,290,716
Foreign currency
translation
-$613
Research and development
$9,802,807
General and
administrative
$6,487,909
Back
Back
Income Statement
source: myfinsight.com
Quoin Pharmaceuticals, Ltd. (QNRX)
Quoin Pharmaceuticals, Ltd. (QNRX)